This is the first in a series of events in which we bring clinicians and medical device engineers to discover unmet needs in a specialized area of medicine. In this event physicians will describe how they treat conditions, some of the challenges they face in delivering quality medical care, and possible solutions; engineers will discuss what is feasible and suggest alternative approaches. Join us for an intensely interactive session focused on pulmonary and critical care medicine.
Set yourself up for success in your startup’s approach to effectively navigate the regulatory pathway to market and maximize your interactions with FDA. Join this seminar to hear from Nada Hanafi, Chief Strategy Officer of Experien Group, headquartered in San Jose, CA. This discussion will focus on the critical success factors that go into a comprehensive regulatory strategy and the benefits of FDA’s Q-Submission process for state-of-the-art medical devices and innovative technologies.
By being in a position to see hundreds of pitches a year, VCs benefit from the opportunity to formulate a unique view of the needs, opportunities, trends, and emerging technologies in a market. Want to get a VC’s perspective on the current state of the medtech landscape and how he anticipates making investment decisions in this environment? Join us on March 26 to hear from Kevin Chu of F-Prime Capital.
Entrepreneur Kara Goldin is the Founder and CEO of hint, Inc., a healthy lifestyle brand that produces the leading, award-winning, unsweetened flavored water, as well as a scented sunscreen spray that is oxybenzone and paraben-free.
Kara has received numerous accolades, including being been named EY Entrepreneur Of The Year 2017 Northern California, one of Fast Company’s Most Creative People in Business, Fortune’s Most Powerful Women Entrepreneurs and Forbes’ 40 Women to Watch Over 40. The Huffington Post listed her as one of six disruptors in business, alongside Steve Jobs and Mark Zuckerberg.
Previously, Kara was Vice President of Shopping and E-commerce Partnerships at AOL, where she helped lead the growth of its startup shopping business to a $1 billion enterprise.
Kara is an active business speaker and writer and, in 2016, she launched The Kara Network, a digital resource and mentoring platform for entrepreneurs. She also recently launched the podcast Unstoppable, where she interviews founders, entrepreneurs and disruptors across various industries.
Natalie Wisniewski, PhD, is co-founder and CTO of Profusa, which develops and markets real-time biosensors that provide unprecedented insights into our overall health status. Together, she and her co-founders, executive team, collaborators and advisors built the company road map, enlisted top talent, secured funding and turned innovative concepts into products. Join us to hear the lessons she has learned as a health tech inventor and entrepreneur.
You’ve developed a compelling value proposition for your physician stakeholders, but what about the hospital who will have to pay for your product? Well before commercializing, entrepreneurs need to consider both clinical and economic positioning for the hospital. How will hospital administration and value analysis committee (VAC) assess your technology and what will it take to get it approved? Join us on February 26 to learn more about selling to the hospital stakeholder with Amie Borgstrom, President of Borgstrom Consulting Group and a former Global Vice President of Marketing for Zimmer Biomet and for Baxano Inc, a venture backed medtech start-up.
To maximize value for stakeholders–and themselves–founders need to make the right decisions concerning financial and legal issues such as capital structure, transactions, scaling, possible exits and personal financial planning. The choices they make today, for example, may have unanticipated consequences with respect to capital raises, taxable income, and income taxes. Join us to hear from this panel of financial and legal experts as they discuss what founders should do to achieve the best possible outcome.
If you are to succeed in commercializing a medical device, you need a clear path to reimbursement. However, the path is often nonintuitive, and increasing globalization has complicated matters. Payers now reference prices from around the world and employ health economics and cost containment tools first seen in pharma. Some companies have adapted by seeking revenue for services beyond the physical product. Join us to get the full briefing from Ali Samiian, Global Head of Market Access, Health Economics and Pricing at Abbott Diabetes Care.
It’s important not just to get funding for your venture but also to ensure that you engage the right investors–people who genuinely want to help you grow and succeed. An expert in investor relations, Caroline Corner is Managing Director at the SF office of Westwicke Partners, a strategic capital markets advisory firm. Join us January 17 to learn what to include in your pitch deck, how to build credibility, and how to connect with quality investors.
What is the right way to raise a seed round? Even as founders strive to focus on innovation and execution, they must make myriad decisions, big and small, on fundraising. Whom should I pitch first? What’s the smallest check I should accept? Do I price the round or raise on a convertible note, and on what terms? Join us as healthcare product designer, entrepreneur, and investor Ryan Pierce tests conventional wisdom against a survey of his peers, considers the ethics of taking early-stage money, and shares his own lessons from both sides of the table.
